API and API Metabolites in Wastewater

API and API Metabolites in Wastewater

To get a quote please complete the form through the button below. A member of our expert team will be in contact with you. Alternatively you can choose to chat to us directly by calling 066 9763588. Our expert customer care team are always happy to help.

What We Can Do For You

Southern Scientific Services works closely with major international pharmaceutical manufacturers. We help our clients develop analytical procedures for detecting and measuring trace quantities of API and API metabolites in wastewater.

Our team of experienced scientists has extensive expertise in this area and is dedicated to delivering our clients the highest standard of service. We work closely with pharmacologists and quality managers at pharmaceutical companies to ensure that our methodology is cutting-edge and fully compliant with industry standards.

Our goal is to help our clients to understand and mitigate any potential environmental impacts of their products and to ensure that they can meet all necessary regulatory requirements. We are proud to be a trusted partner to some of the world’s leading pharmaceutical manufacturers and are committed to helping them achieve their research and development goals.

Get a quote for your work today! 👇

Get a Quote API and API Metabolites Today! 

What you should know about our API Metabolites in Wastewater.

What are API Metabolites?

API (Active pharmaceutical ingredient) metabolites are chemical compounds produced as the body metabolizes medication. These metabolites are often present in small amounts in the urine or faeces of an individual taking the medication.

API metabolites may be present in wastewater if many people in a particular area take the medication and excrete the metabolites into the sewage system. They can be an indicator of the level of medication use in a community, and can be useful in public health studies.

The presence of API metabolites in the environment can indicate the potential for negative effects on non-target species and the potential for pharmaceuticals to enter the food chain and affect human health.

However, it is important to note that API metabolites do not necessarily indicate that the medication is being used improperly or causing negative effects on public health.

Who Should Test For API Metabolites?

Analysis of API and API Metabolites in Wastewater is recommended for pharmaceutical manufacturers.

API metabolites are not typically tested for in individuals as they are present in small amounts and not used to diagnose or monitor health conditions. Instead, API metabolites are more commonly measured in large populations, such as in the wastewater of a particular area or the blood or urine of a group of people.

This is done to understand medication use and potential public health effects in a population, often for public health research or environmental monitoring. Testing for API metabolites is typically not necessary for individual patients or healthcare providers.

Why Test For API Metabolites in Wastewater?

Pharmaceuticals play an essential role in ensuring a high level of public health. Increased use of pharmaceuticals has caused their concentration to increase in environmental reservoirs in the past 20 years.

The largest source of pharmaceuticals entering the environment is their use and disposal. Therefore, pharmaceutical companies may choose to test for API metabolites in wastewater for various reasons.

One reason is to understand the level of medication use in a particular population and any potential public health effects. By analyzing the API metabolites present in wastewater, pharmaceutical companies can gain valuable insights into the medications being used in a particular area.

They can use this information to inform the development of new medications or to understand the potential impacts of their existing products. Testing for API metabolites in wastewater may also be done for regulatory purposes to demonstrate the safety and effectiveness of a particular medication.

Additionally, pharmaceutical companies may be interested in testing for API metabolites in wastewater. This process helps them better understand their products’ environmental impacts and ensure that they meet all necessary regulatory requirements.

Shopping cart0
There are no products in the cart!
Continue shopping